UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029816
Receipt No. R000034063
Official scientific title of the study Novel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial
Date of disclosure of the study information 2017/11/03
Last modified on 2018/01/17 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Novel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial
Title of the study (Brief title) Novel treatment for refractory neuroblastoma by using poliovirus; phase I clinical trial
Region
Japan

Condition
Condition refractory neuroblastoma
Classification by specialty
Pediatrics
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 safety and efficacy
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes safety (paralysis) and efficacy (anti-tumor effect) at 6 months after administration
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 intratumoral administration of poliovirus
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 months-old <=
Age-upper limit
120 months-old >
Gender Male and Female
Key inclusion criteria refractory neuroblastoma
Key exclusion criteria patients who have paralysis
Target sample size 3

Research contact person
Name of lead principal investigator Hidemi Toyoda
Organization Mie University Hospital
Division name Pediatrics
Address 2-174 Edobashi, Tsu
TEL 059-232-1111
Email htoyoda@clin.medic.mie-u.ac.jp

Public contact
Name of contact person Hidemi Toyoda
Organization Mie University Hospital
Division name Pediatrics
Address 2-174 Edobashi, Tsu
TEL 059-232-1111
Homepage URL
Email htoyoda@clin.medic.mie-u.ac.jp

Sponsor
Institute Mie University
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2009 Year 12 Month 15 Day
Anticipated trial start date
2009 Year 12 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 11 Month 03 Day
Last modified on
2018 Year 01 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034063